Volume 19 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
WANG Pan, WANG Yichao, YU Dandan, CHEN Wenju, ZHONG Qianyi, TONG Binxin. Expression of microRNA-1246 in the serum of hepatocellular carcinoma and its effect on biological function of HepG2 cells[J]. Chinese Journal of General Practice, 2021, 19(8): 1292-1295,1313. doi: 10.16766/j.cnki.issn.1674-4152.002043
Citation: WANG Pan, WANG Yichao, YU Dandan, CHEN Wenju, ZHONG Qianyi, TONG Binxin. Expression of microRNA-1246 in the serum of hepatocellular carcinoma and its effect on biological function of HepG2 cells[J]. Chinese Journal of General Practice, 2021, 19(8): 1292-1295,1313. doi: 10.16766/j.cnki.issn.1674-4152.002043

Expression of microRNA-1246 in the serum of hepatocellular carcinoma and its effect on biological function of HepG2 cells

doi: 10.16766/j.cnki.issn.1674-4152.002043
Funds:

 2018C37037

 1901ky35

  • Received Date: 2020-08-06
    Available Online: 2022-02-16
  •   Objective  To investigate the expression of microRNA-1246 (miR-1246) in hepatocellular carcinoma (HCC) serum and its effect on the biological function of HepG2 cells.  Methods  Serum miR-1246 was determined by qRT-PCR in HCC patients and healthy controls. MiR-1246 mimics and NC mimics were transfected into HepG2 cells separately. The effect of miR-1246 on the biological function of HepG2 cells was examined by transwell chamber assay, scratch test and cell clone formation test. The expression of NFE2L3, Vimentin and GAS1 were detected by qRT-PCR.  Results  The expression levels of miR-1246 in the serum of healthy controls and HCC patients were 1.079 (0.740, 1.534) and 0.132 (0.068, 0.324), respectively, and the difference was statistically significant (P < 0.001). After transfection of miR-1246 mimics into HepG2 cells, the number of HepG2 cells passing through matrigel was (128.000±9.900), which was significantly lower than that of the NC mimic group (251.500±24.749, P=0.023). Forty-eight hours after scratch, the relative mobility of HepG2 cells was (24.833±3.351) %, which was significantly lower than that in the NC mimic group (31.859±7.194) % (P=0.046). The relative expression levels of Vimentin, GAS1 and NFE2L3 were (0.318±0.213), (0.479±0.157) and (0.755±0.044), respectively, which were significantly lower than those in the NC mimic group (P=0.046, P=0.043 and P=0.030, respectively).  Conclusion  The expression levels of miR-1246 were decreased in HCC serum. MiR-1246 could inhibit the invasion and migration of HepG2 cells by down-regulating the expression of Vimentin, GAS1 and NFE2L3.

     

  • loading
  • [1]
    BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
    [2]
    ZHANG P, SHAO G G, LIN X Y, et al. MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2[J]. Am J Cancer Res, 2017, 7(1): 53-63. http://ajcr.us/files/ajcr0046441.pdf
    [3]
    王攀, 赵玲萍, 朱杰, 等. 乳腺癌细胞中miR-1246、ZO-1、vimentin的表达及相关性研究[J]. 中华全科医学, 2016, 14(8): 1373-1375. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201608043.htm
    [4]
    GHEYTANCHI E, MADJD Z, JANANI L, et al. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol[J]. Syst Rev, 2017, 6(1): 228. doi: 10.1186/s13643-017-0624-2
    [5]
    YANG F M, NING Z Q, MA L, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts[J]. Mol Cancer, 2017, 16(1): 148. doi: 10.1186/s12943-017-0718-4
    [6]
    MALLA B, ZAUGG K, VASSELLA E, et al. Exosomes and exosomal microRNAs in prostate cancer radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2017, 98(5): 982-995. doi: 10.1016/j.ijrobp.2017.03.031
    [7]
    李义. 血清miR-122作为肝癌手术预后的血清标志物的研究[J]. 中国医药导刊, 2016, 18(1): 93-94, 98. https://www.cnki.com.cn/Article/CJFDTOTAL-DKYY201601052.htm
    [8]
    曾勇, 程朋, 官泳松. 恩度联合动脉灌注化疗栓塞(TACE)治疗后原发性肝癌恶性程度的评估[J]. 海南医学院学报, 2016, 22(8): 799-802, 806. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201608021.htm
    [9]
    CAO F, YIN L X. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway[J]. Exp Mol Pathol, 2019, 106: 34-43. doi: 10.1016/j.yexmp.2018.10.009
    [10]
    冯一鸣, 姚德生, 卢艳, 等. 宫颈鳞癌患者血清miR-1246的表达及其临床意义[J]. 肿瘤防治研究, 2019, 46(6): 532-536. doi: 10.3971/j.issn.1000-8578.2019.18.1727
    [11]
    HUANG W H, LI H F, LUO R C. The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4[J]. Diagn Pathol, 2015, 10: 127. doi: 10.1186/s13000-015-0366-1
    [12]
    丁元杰, 马箐, 郭旭东, 等. 食管鳞癌患者血清差异表达miRNAs的筛选[J]. 山东医药, 2018, 58(15): 1-4. doi: 10.3969/j.issn.1002-266X.2018.15.001
    [13]
    解学军, 张冰. 外泌体MicroRNA-1246促进星形胶质瘤细胞增殖与侵袭的研究[J]. 中华细胞与干细胞杂志(电子版), 2018, 8(5): 292-296. doi: 10.3877/cma.j.issn.2095-1221.2018.05.006
    [14]
    ZHANG Q, CAO L Y, CHENG S J, et al. P53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB[J]. Oncol Rep, 2015, 33(3): 1335-1341. doi: 10.3892/or.2015.3715
    [15]
    彭兆意, 周喜洋. miR-1246在肝癌组织中的表达及其对人肝癌细胞增殖和凋亡的影响[J]. 肝胆胰外科杂志, 2016, 28(2): 98-101. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYW201602004.htm
    [16]
    SUN Z, MENG C T, WANG S H, et al. MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma[J]. BMC Cancer, 2014, 14: 616. doi: 10.1186/1471-2407-14-616
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Article Metrics

    Article views (276) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return